Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Sarcoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01588678
What this trial is testing

A Open-Label, Multiple Ascending Dose Study of DS-3078a, an Oral TORC1/2 Kinase Inhibitor, in Subjects With Advanced Solid Tumors or Lymphomas

Who this might be right for
Advanced Solid TumorLymphoma
Daiichi Sankyo 32
Early research (Phase 1)Study completedNCT05114668
What this trial is testing

Safety, Tolerability, and Pharmacokinetics of EVT801 in Patients With Advanced Solid Tumours

Who this might be right for
Solid Tumor, Adult
Kazia Therapeutics Limited 32
Not applicableUnknownNCT05615545
What this trial is testing

Cryoablation for Advanced Bone and Soft Tissue Tumors

Who this might be right for
SarcomaCryoablation
Henan Cancer Hospital 30
Large-scale testing (Phase 3)Study completedNCT02818725
What this trial is testing

I-MVAC +/- Panitumumab as First-line Treatment of Advanced Urothelial Carcinoma Without H-Ras Nor K-Ras Mutations

Who this might be right for
Infiltrating Urothelial CarcinomaKRAS Gene Mutation
UNICANCER 133
Early research (Phase 1)Study completedNCT01139346
What this trial is testing

Study of Oral Darinaparsin in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Alaunos Therapeutics 12
Testing effectiveness (Phase 2)Looking for participantsNCT03093116
What this trial is testing

Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

Who this might be right for
Locally Advanced Solid TumorsMetastatic Solid Tumors
Turning Point Therapeutics, Inc. 500
Testing effectiveness (Phase 2)Ended earlyNCT03132155
What this trial is testing

QUILT-3.031: AMG 337 in Subjects With Advanced or Metastatic Clear Cell Sarcoma

Who this might be right for
Clear Cell Sarcoma
NantPharma, LLC 8
Testing effectiveness (Phase 2)Study completedNCT00918489
What this trial is testing

Study on Efficacy and Tolerability of Vorinostat in Patients With Advanced, Metastatic Soft Tissue Sarcoma (STS)

Who this might be right for
Soft Tissue Sarcoma
Heidelberg University 40
Testing effectiveness (Phase 2)Looking for participantsNCT04094610
What this trial is testing

Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations

Who this might be right for
Locally Advanced Solid TumorsMetastatic Solid TumorsLymphoma+1 more
Turning Point Therapeutics, Inc. 75
Testing effectiveness (Phase 2)WithdrawnNCT05174455
What this trial is testing

Niraparib for the Treatment of Leiomyosarcoma

Who this might be right for
Locally Advanced LeiomyosarcomaMetastatic LeiomyosarcomaStage III Retroperitoneal Sarcoma AJCC v8+4 more
David Liebner, MD
Testing effectiveness (Phase 2)Looking for participantsNCT07193550
What this trial is testing

Trial of Zanzalintinib in Advanced/Metastatic Bone Sarcomas (ZAMBONE)

Who this might be right for
Bone Sarcomas
M.D. Anderson Cancer Center 70
Early research (Phase 1)Study completedNCT02326025
What this trial is testing

Olaratumab and Doxorubicin in Participants With Advanced Soft Tissue Sarcoma

Who this might be right for
Sarcoma, Soft Tissue
Eli Lilly and Company 49
Testing effectiveness (Phase 2)Looking for participantsNCT05894018
What this trial is testing

Brachytherapy (Iodine-125 Seeds) and Fluzoparib Combination Therapy for Advanced Unresectable Soft Tissue Sarcoma

Who this might be right for
Sarcoma,Soft TissueBrachytherapyPoly(ADP-ribose) Polymerase Inhibitors
Fujun Zhang 32
Large-scale testing (Phase 3)Study completedNCT00061984
What this trial is testing

Doxorubicin With or Without Ifosfamide and Pegfilgrastim in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma

Who this might be right for
Sarcoma
European Organisation for Research and Treatment of Cancer - EORTC 455
Testing effectiveness (Phase 2)Study completedNCT03802071
What this trial is testing

Durvalumab in Combination With Doxorubicin for Advanced Soft Tissue Sarcoma

Who this might be right for
Sarcoma
Yonsei University 44
Early research (Phase 1)Ended earlyNCT00288444
What this trial is testing

Interaction of Docetaxel and Lonafarnib in Patients With Advanced Cancer

Who this might be right for
Lung CancerSoft Tissue SarcomaColorectal Carcinoma+2 more
Emory University 38
Large-scale testing (Phase 3)WithdrawnNCT06370871
What this trial is testing

Brightline-3: A Study to Find Out Whether Brigimadlin in Combination With Ezabenlimab Helps People With Advanced Soft Tissue Sarcoma

Who this might be right for
Advanced Soft Tissue SarcomaUndifferentiated Pleomorphic Sarcoma (UPS)Myxofibrosarcoma (MFS)
Boehringer Ingelheim
Early research (Phase 1)Study completedNCT03752398
What this trial is testing

XmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3)

Who this might be right for
Melanoma (Excluding Uveal Melanoma)Cervical CarcinomaPancreatic Carcinoma+13 more
Xencor, Inc. 198
Early research (Phase 1)Study completedNCT01061840
What this trial is testing

Trial of Bi-shRNA-furin and GMCSF Augmented Autologous Tumor Cell Vaccine for Advanced Cancer

Who this might be right for
Ewings SarcomaNon Small Cell Lung CancerLiver Cancer
Gradalis, Inc. 100
Testing effectiveness (Phase 2)UnknownNCT03792542
What this trial is testing

Anlotinib Hydrochloride For Advanced Soft Tissue Sarcoma Patients Who Do Not Receive Chemotherapy

Who this might be right for
Soft Tissue Sarcoma
Second Affiliated Hospital, Zhejiang University, School of Medicine 44
Next Page